4Andersson S, Safari H, Mints M, et al. Type distribution,viral load andintegration status of high-risk human papillomavirus in pre-stages of cervical cancer CIN [J]. Br J Cancer,2005,92 ( 12 ) :2195 - 2200.
5Wright TC Jr, vSchiffman M,vSolomon D,et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening [ J ]. Obstet Gynecol,2004,103 (2) :304 - 309.
7Pan Q, Belinson JL, Li L,et al. A thin-layer, liquid-based pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A crosssectional, comparative study [ J ]. Acta Cytol,2003,47 (1) :45 -50.
8Tsuda H,Hashiguchi Y,Nishimura S,et al. Relationship between HPV typing and abnormality of GI cell cycle regulators in cervical neoplasm [J].Gynecol Oncol,2003,91 (3) : 476 - 485.
10Tsai H J, Wu CH,Lai HL,et al. Association between quantitative highrisk human papillomavirus DNA load and cervical intra epithelial neoplasm risk [ J ]. Cancer Epidemiol Biomarkers Prey,2005,14 ( 11 Pt1) : 2544 - 2549.
2Liu VW,Tsang P, Yip A,et al. Low incidence of HPV- DNA in sera of pretreatment cervical cancer patients[J]. Gynecol Oncol,2001,82 (2) :269.
3Dong SM,Pai SI, Rha SH, et al. Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma[J]. Cancer Ep idemiol Biomarkers Prev, 2002,11 ( 1 ) : 3.
4Sathish N, Abraham P, Peedicayil A, et al. HPV DNA in plasma of patients with cervical carcinoma[J]. J Clin Virol, 2004,31(8):204.
5Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis[]]. Cancer, 1995, 76(10 suppl) :1888-1901
6Zur Hausen H. PapiUomavirus Causing cancer: Evasion from host-cell control in early events in carcinogenesis[J].J Nad cancer Inst, 2000, 92(9):690-698
7Burd EM. Human papiUomavirus and Cervical cancer [J]. Clin Micro Rev, 2003, 16(1) :1 - 17
8Bekkers BL, Massuger LF, Bumen J, et al. Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer[J]. Rev Med Virol, 2004, 14(2):95 - 105
9Cuziek J,Arbyn M,Sankaranarayanan R,et al.Overview of human papillomavirua-based and other novel options for cervical cancer screening in developed and developing countries[J].Vaccine,2008,26(52):6743-6744.
10Heselmeyer Haddad K,Sommerfeld K,White NM,et al.Genomic amplification of the human telomerase gene(hTERC)in pap smears predicts the development of cervical cancer[J].American Journal of Pathology,2005,166(4):1229-1238.
